We saw average cost savings of $6,396 per GLP-1 patient, driven by decreases in avoidable imaging (93%) and high-cost diagnostic procedures (90%) Combined with an average reduction of 64% in ER visits across Oshis full patient population, the savings for buyers were substantial
Lowering Caloric Intake: By controlling appetite and increasing feelings of satiety, you naturally consume fewer calories
Does the location show an industrial or manufacturing facility, or an apartment building
(Source: lan Clinic, June 2026) Relative Risk Compared to Placebo A systematic review published in the Journal of Clinical Investigation quantified the increased nausea risk for each newer-generation therapy against placebo: Worth noting: Semaglutide and tirzepatide show nearly identical nausea risk 2.95 versus 2.90 relative to placebo
This data is essential for a provider to determine if you are a candidate for a GLP-1 program
Peer-reviewed research isnt infallible, but its subjected to scientific scrutiny that social media posts arent